Invented by David McDaniel, director of the Institute of Anti-Aging Research and developed by Light BioScience, the system has become widely used by dermatologists and plastic surgeons as a non-invasive approach to skin rejuvenation.
The technology is likely to interest companies competing in the rapidly growing market for light-based anti-aging and skin rejuvenation treatments, and it is estimated that it could generate sales of around $70m per year.
FDA approval
Light BioScience was given the green light by the FDA for the technology in February 2008, adding to a growing number of home treatments in this category.
The Virginia-based company says that the approval of its GentleWaves LED Photomodulation technology makes it the first company to be given clearance for a device that treats periorbital wrinkles.
The FDA approval meant that the technology could be bought on an over-the-counter basis, eradicating the need for a qualified beauty therapist or dermatologist to carry out the treatment.
Amber-colored LED targets wrinkles
The technology uses amber-colored LEDs to target fine lines and wrinkles, in turn helping to stimulate collagen production, while also slowing down collagen breakdown, the manufacturers claim.
Invented by David McDaniel, M.D. and director of the Institute of Anti-Aging Research, the treatment is also said to be non-ablative, and has no pain or other side effects.
Light-based treatments have become a popular means of treating both wrinkles and acne, particularly in the European and US markets.
Tapping into a growing market
The latest development in that particular market is the rise of hand-held technologies that can be administered in the home.
Other companies marketing these kind of technologies include a partnership between Cynosure and Unilever and Palomar Medical Technologies.
During 2008 the number of non-invasive medical procedures carried out in the US rose by 5 percent to 10.4 million, according to figures from American Society of Plastic Surgeons.